By Crystal Phend, Senior Staff Writer, MedPage Today
The sexually transmitted infection Trichomonas vaginalis increases risk of clinically-relevant, aggressive prostate cancer, researchers affirmed.
Men with antibodies to T. vaginalis were more than twice as likely to develop tumors that spread outside the prostate and that ultimately led to bony metastases or prostate cancer-specific death, Jennifer R. Stark, ScD, of the Harvard School of Public Health, and colleagues found.
Read More
No comments:
Post a Comment